CHEMICAL WORLD THIS WEEK
RESEARCH
the facts, \bout
Insulin given a l o n g w i t h cortisone m a y cut costs of rheumatoid arthritis therapy by reducing effective dosage of cortisone, say Schering researchers \ γ / Η Α ΐ itut> prove to be a revolutionary dev elopment in the treatment of rheu matoid arthritis was disclosed recently in α preliminary report by E d w a r d Henderson. John YV. Cra> . Marvin Weinberg, Evelyn Z. Merrick, and Harry Seneca. The1 work is published in the Journal of Clinical Eiulocriiiohifiy. These scientists disco\ < ed that when insulin, the hormone use \ diabetes, is given simultaneously with cortisone, smaller doses or* cortisone than heretofore used may be effective. This combination was reported to produce the same degree of relief in arthritis as when cortisone is used alone in the customary large doses. T h e principle or using insulin together with cortisone was developed by Dr. Henderson, director or the clinical r e search division of Schering Corp., and by Dr. Weinberg, his associate, on the* basis of animal and laboratory experiments con ducted at the College of Physicians and Surgeons of Columbia University by a third member ot the Schering team. Dr. Seneca. Through the cooperation of George C. Scbicks, director of St. Barnabas Hospital, Newark, X. J., a n d with Dr. Gray, rheumatologist and director of the arthritis clinic at St. Barnabas, and his associate. Dr. Merrick, special arrangements for an advanced research program were worked out. T h e research workers have stated that t h e new method does not merely cut t h e cost of treatment to one half or less b u t also offers a means of avoiding some of t h e dangerous actions ot the drug.
The finer STABILIZER EMULSIFIER · THICKENER GELLING AGENT SUSPENDING AGENT I n o n e b o o k l e t a r e fact.- you Λ \ ; Ι Π Ι !
